NCT00795938

Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.

An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of An Experimental Tablet Of Sildenafil With Or Without Water Relative To Viagra® Conventional Oral Tablet With Water.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study to will compare the blood levels of sildenafil following administration of an experimental tablet vs. the conventional oral tablet.

Conditions

• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	Sildenafil	Single Dose of 50 mg Sildenafil Oral Tablet With Water
DRUG	Sildenafil	Single Dose of 50 mg Sildenafil Experimental Tablet With Water
DRUG	Sildenafil	Single Dose of 50 mg Sildenafil Experimental Tablet Without Water

Timeline

• Start date: 2008-10-01
• Primary completion: 2008-11-01
• Completion: 2008-11-01
• First posted: 2008-11-21
• Last updated: 2021-02-01

Locations

1 site across 1 country: United States